For the supply of Pulmicort Turbohaler 400

Official notice

Authority: Department of Health & Social Care (Central government)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: UK

Awarded value£1,083,200published contract · exc. VAT

Awarded 23 Feb 2022no call for competition

Awarded to ASTRAZENECA UK LIMITED

What is being bought

Published requirement description

The Department of Health and Social Care (DHSC) has awarded Contract for the Supply of Pulmicort Turbohaler 400mg.

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published

Lot #1The Department of Health and Social Care conducted a Direct Award under the Regulation…Awarded

The Department of Health and Social Care conducted a Direct Award under the Regulation 32(2)(b)(iii) of the Public Contracts Regulations 2015 (as amended) for the supply of Pulmicort Turbohaler 400 mg. The contract period expires on 31 March 2022.

Delivery: UK

Procedure terms & legal framework

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 25 Apr 2022, 10:47 BST
Last source update: 25 Apr 2022, 10:47 BST
Authority reference: CM/EMP/21/70704
FTS notice number: 2022/S 000-010567
Classification (CPV): Pharmaceutical products
Delivery area: UK
Official registry OCID: ocds-h6vhtk-032fe5 Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
Published justification: The Authority used the negotiated procedure without prior publication under Regulation 32(2)(b)(iii) – to protect exclusive rights to purchase a quantity of Pulmicort Turbohalers 400mg. The Supplier has exclusive rights to manufacture and distribute the Pulmicort Turbohalers 400mg. This product has a unique mechanism capable of delivering a precise dose to patients and has a proven clinical effect on the treatment of individuals with COVID-19 and other illnesses. This unique delivery system means there are no suitable or reasonable alternatives to this product.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £1,083,2001 contract exc. VAT

Bids received 1

Contracts signed 1latest 23 Feb 2022

Awarded to	Value	Date	Status
ASTRAZENECA UK LIMITED	£1,083,200 †	—	Awarded

Contracts

Contract 010567-2022-1 · ASTRAZENECA UK LIMITED
Signed
23 Feb 2022
Value
£1,083,200
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authority & participating public bodies

Department of Health and Social Care

Contracting authorityCentral GovernmentMinistry or any other national or federal authority, including their regional or local subdivisionsHealth 39 Victoria Street, London, London, SW1H 0EUContact name, email

Dispute resolution & review bodies

The High CourtReview body LondonContact email

Bidders & participating suppliers

1 commercial party on the notice

ASTRAZENECA UK LIMITEDAwarded supplier03674842 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA, Cambridge, East of England, LCB2 0AA

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.